Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Routine obstetric medications and maternal heart rate variability
NL-OMON23599Not yet recruiting
- Sponsor
- Philips
- Start
- Apr 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of betamethasone in preterm birth, Preterm prelabor rupture of membranes (PPROM), maternal hypertension (HDP) and 1 more, sponsored by Philips. Planned start Apr 2020; status: not yet recruiting.
02
Drugs
betamethasone
03
Conditions
preterm birthPreterm prelabor rupture of membranes (PPROM)maternal hypertension (HDP)antepartum hemorrhage (APH)
Beyond the preview
Go deeper on NL-OMON23599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23599.